When it comes to profound depression many people just cant get relief from current treatments Now theres more evidence that the anesthetic ketamine   as a club drug has potential as a fastacting treatment for the condition Doctors at the Mayo Clinic gave  patients ketamine twice a week as an infusion that lasted  minutes All the people had depression that had resisted other treatments The patients got ketamine until their symptoms abated or theyd had four infusions of the drug Half the people were pretty much free of symptoms of depression after treatment And two of those people were still in remission a month afterward The   in the   It is surprising to see people respond like this says   medical director at the Mayo Clinic Psychiatric Hospital and a coauthor of the study But he tells Shots its a pretty evanescent response People get better quickly but they also relapse quickly All the patients except one in this study were taking conventional antidepressant drugs during the followup period it should be said And in this study unlike some others all the patients got ketamine so there was no comparison group Both doctors and patients knew that ahead of time too Ketamine works Lineberry says Its safe The question is how to translate it into a maintenance model It may turn out that ketamine needs to be given regularly say weekly or perhaps an initial course of treatment could pave the way for more effective talk therapy Lineberry says ketamine treatment remains an area for further study at Mayo rather than standard practice right now There are questions about which patients are suited for ketamine therapy  and which ones arent The Mayo study for instance excluded people with a history of psychotic disorders and previous problems with drug and alcohol abuse While still not routine the use of ketamine and related drugs for depression is getting traction Johnson  Johnsons Janssen drug division has been testing ketamine infusions and a   that can be taken through the nose If successful that approach would make it possible for patients to take the drug outside of a clinic or hospital The company also says the nasal formula could help minimize side effects such as hallucinations and anxiety At a   the company said early esketamine results looked promising The drug is in the second of three phases of clinical studies that are necessary to seek approval from the Food and Drug Administration